Cardiovascular & Metabolic

A heart for the details.

When developing therapies that help patients with cardiac or metabolic conditions, we’re right there with you. From molecule to market, we help you strategically ace the details in between. Details like imaging strategies, feasibility studies, recruitment solutions, and more. Because our team has a deep understanding of conducting these types of clinical development activities, Parexel can help you stay on top of challenges before they become issues.

Strengths of our Cardiovascular and Metabolism team include:
  • Extensive work with medical feasibility studies, data-driven management of recruitment, enrollment, and retention providing critical data about regions, countries, sites, investigators, standards/quality of care, and competing trials
  • Strength managing complex trials in Phase I-IV on every continent, with Best Practice Management across the entire therapeutic area
  • Industry leaders in central review of medical imaging/clinical data
  • Comprehensive understanding of drug development, regulatory consulting, and commercialization
  • Ongoing activities in academia, clinical practice, and research backgrounds
  • Established associations with Key Opinion Leaders in different fields of Cardiovascular Disease (e.g., ESC Task Force members)
  • Relationships with major academic research centers
  • Established relationship with recognized CV experts for CEC and DSMB panels; and MEGA Trials, Endpoint Trials (MACE, CV Mortality), Atrial fibrillation, CHF, ACS and AMI, and Antiplatelet Tx – CV prophylaxis


We are always available for a conversation.